Filippo Vaccher

ORCID: 0000-0002-4434-0133
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Radiomics and Machine Learning in Medical Imaging
  • COVID-19 diagnosis using AI
  • Advanced Radiotherapy Techniques
  • Aortic Disease and Treatment Approaches
  • Vasculitis and related conditions
  • Artificial Intelligence in Healthcare and Education
  • Radiology practices and education
  • Cardiac, Anesthesia and Surgical Outcomes
  • Infective Endocarditis Diagnosis and Management
  • Machine Learning in Healthcare
  • Medical Imaging Techniques and Applications
  • Ultrasound in Clinical Applications
  • Abdominal vascular conditions and treatments
  • Glioma Diagnosis and Treatment
  • Sarcoidosis and Beryllium Toxicity Research
  • Adrenal and Paraganglionic Tumors
  • Viral Infections and Immunology Research
  • COVID-19 and healthcare impacts
  • Cardiac Arrest and Resuscitation
  • Infectious Diseases and Tuberculosis
  • Pericarditis and Cardiac Tamponade
  • IgG4-Related and Inflammatory Diseases
  • Emergency and Acute Care Studies
  • Cancer, Hypoxia, and Metabolism
  • Pulmonary Hypertension Research and Treatments

University of Brescia
2020-2025

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2020-2022

Surgical Specialties (Canada)
2020

University of Verona
2018

This article's main contributions are twofold: 1) to demonstrate how apply the general European Union's High-Level Expert Group's (EU HLEG) guidelines for trustworthy AI in practice domain of healthcare and 2) investigate research question what does "trustworthy AI" mean at time COVID-19 pandemic. To this end, we present results a post-hoc self-assessment evaluate trustworthiness an system predicting multiregional score conveying degree lung compromise patients, developed verified by...

10.1109/tts.2022.3195114 article EN cc-by-nc-nd IEEE Transactions on Technology and Society 2022-07-29

We evaluated tumor response at Computed Tomography (CT) according to three radiologic criteria: RECIST 1.1, CHOI and volume in 34 patients with metastatic adrenocortical carcinoma (ACC) submitted standard chemotherapy. These criteria agreed defining partial response, stable or progressive disease 24 (70.5%). Partial (PR) was observed 29.4%, 29.4% 41.2% of volume, respectively. It associated a favorable prognosis, regardless the criterion adopted. The concordance all 3 identified 8 (23.5%)...

10.3390/cancers12061395 article EN Cancers 2020-05-28

To evaluate the performance of a clinical-radiological index (RAPID-Covid score) in achieving Safe Discharge (SD) patients accessing Emergency Department (ED) with symptoms suggesting Covid-19. Clinical and radiological data were retrospectively collected from 853 consecutive admitted to ED during pandemics Illness severity was graded RAPID-Covid score, composed chest X-ray findings, clinical PaO2/FiO2. Patients RAPIDCovid score ≥5 admitted. Primary outcome SD home care. defined as survival...

10.4081/ecj.2020.9192 article EN cc-by-nc Emergency Care Journal 2020-12-23

Background: The standard treatment for locally advanced non-small cell lung cancer (LA-NSCLC) is represented by concomitant chemo-radiotherapy followed consolidation with durvalumab that ensures a 5-year survival of 46%. However, the risk radiotherapy-induced pneumonia (RIP) almost 10–15%. Complete cardiological examination also usually performed during cardiopulmonary pre-treatment evaluation and pulmonary function testing one most used tool to predict RIP development. Aim: aim this study...

10.3390/app12189351 article EN cc-by Applied Sciences 2022-09-18
Coming Soon ...